Araştırma Makalesi

Measurement of Anxiety Levels in Differentiated Thyroid Cancer Patients

Cilt: 15 Sayı: 3 15 Eylül 2025
PDF İndir
TR EN

Measurement of Anxiety Levels in Differentiated Thyroid Cancer Patients

Öz

In this study, our aim was to determine the anxiety levels of patients diagnosed with DTC and to investigate the relationships between anxiety and factors such as age, sex, marital status, the presence of metastasis, time since diagnosis, whether they received RIT, and the dose of radioactive iodine they received. This prospective study was conducted between January 2024 and June 2024. Clinical findings and demographic data of 164 patients who applied to the nuclear medicine outpatient clinic were recorded, and anxiety levels were measured via the Beck Anxiety Inventory. Statistical analyses were performed via SPSS 23.0. The statistical significance level was accepted as p<0.05. When the gender of the patients was compared with the Beck anxiety level, a statistically significant relationship was found (p=0.007). No significant relationship was found between the marital status, the presence of metastasis, the status of receiving radioactive iodine treatment or histopathological subtype and the Beck anxiety level. Anxiety levels in patients with differentiated thyroid cancer were found to be significantly higher in females than in males.

Anahtar Kelimeler

Etik Beyan

Before starting the study, ethical approval was obtained from the Pamukkale University Non-Interventional Clinical Research Ethics Committee (dated 26.12.2023 and numbered 21).

Teşekkür

We would like to thank Miyase Nur ATALAY, Mert CENGİZ and Yavuz ÖZLÜ for their data entry of patient information.

Kaynakça

  1. 1. Lepore SJ, Coyne JC. Psychological interventions for distress in cancer patients: a review of reviews. Ann Behav Med. 2006;32(2):85- 92.
  2. 2. Sloan PA, LaFountain P, Plymale M, Johnson M, Snapp J, Sloan DA. Cancer pain education for medical students: the development of a short course on CD-ROM. Pain Med. 2002;3(1):66-72.
  3. 3. Tokgöz G, Yalu İ, Özdemir S, Yazıcı A, Uygun K, Aker T. Kanser hastalarında majör depresyon yaygınlığı ve ilişkili etkenler. Anadolu Psikiyatri Dergisi 2008;9:59-66.
  4. 4. Berard RM. Depression and anxiety in oncology: the psychiatrist's perspective. J Clin Psychiatry. 2001;62 Suppl 8:58-61; discussion 62- 3.
  5. 5. Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229-63.
  6. 6. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26(1):1-133.
  7. 7. Brito JP, Ito Y, Miyauchi A, Tuttle RM. A Clinical Framework to Facilitate Risk Stratification When Considering an Active Surveillance Alternative to Immediate Biopsy and Surgery in Papillary Microcarcinoma. Thyroid. 2016;26(1):144-9.
  8. 8. Albalawi IA, Mirghani HO. Lobectomy versus total thyroidectomy in differentiated thyroid carcinoma: A review. AMJ 2019;12(10):285– 91.

Ayrıntılar

Birincil Dil

İngilizce

Konular

Nükleer Tıp

Bölüm

Araştırma Makalesi

Yayımlanma Tarihi

15 Eylül 2025

Gönderilme Tarihi

14 Ocak 2025

Kabul Tarihi

12 Mayıs 2025

Yayımlandığı Sayı

Yıl 2025 Cilt: 15 Sayı: 3

Kaynak Göster

APA
Gültekin, A., & Şengöz, T. (2025). Measurement of Anxiety Levels in Differentiated Thyroid Cancer Patients. Bozok Tıp Dergisi, 15(3), 255-262. https://doi.org/10.16919/bozoktip.1619616
AMA
1.Gültekin A, Şengöz T. Measurement of Anxiety Levels in Differentiated Thyroid Cancer Patients. Bozok Tıp Dergisi. 2025;15(3):255-262. doi:10.16919/bozoktip.1619616
Chicago
Gültekin, Aziz, ve Tarık Şengöz. 2025. “Measurement of Anxiety Levels in Differentiated Thyroid Cancer Patients”. Bozok Tıp Dergisi 15 (3): 255-62. https://doi.org/10.16919/bozoktip.1619616.
EndNote
Gültekin A, Şengöz T (01 Eylül 2025) Measurement of Anxiety Levels in Differentiated Thyroid Cancer Patients. Bozok Tıp Dergisi 15 3 255–262.
IEEE
[1]A. Gültekin ve T. Şengöz, “Measurement of Anxiety Levels in Differentiated Thyroid Cancer Patients”, Bozok Tıp Dergisi, c. 15, sy 3, ss. 255–262, Eyl. 2025, doi: 10.16919/bozoktip.1619616.
ISNAD
Gültekin, Aziz - Şengöz, Tarık. “Measurement of Anxiety Levels in Differentiated Thyroid Cancer Patients”. Bozok Tıp Dergisi 15/3 (01 Eylül 2025): 255-262. https://doi.org/10.16919/bozoktip.1619616.
JAMA
1.Gültekin A, Şengöz T. Measurement of Anxiety Levels in Differentiated Thyroid Cancer Patients. Bozok Tıp Dergisi. 2025;15:255–262.
MLA
Gültekin, Aziz, ve Tarık Şengöz. “Measurement of Anxiety Levels in Differentiated Thyroid Cancer Patients”. Bozok Tıp Dergisi, c. 15, sy 3, Eylül 2025, ss. 255-62, doi:10.16919/bozoktip.1619616.
Vancouver
1.Aziz Gültekin, Tarık Şengöz. Measurement of Anxiety Levels in Differentiated Thyroid Cancer Patients. Bozok Tıp Dergisi. 01 Eylül 2025;15(3):255-62. doi:10.16919/bozoktip.1619616